New Lipid Guidelines

Register Now!

By participating in this CardioCore Foundational Lecture, you will better understand how the 2026 ACC/AHA Multi-society Dyslipidemia Guideline translates into practical, patient-centered care, specifically how to (1) assess cardiovascular risk using contemporary tools, (2) initiate and intensify lipid-lowering therapy based on individualized risk, and (3) apply updated treatment targets including LDL-C, non–HDL-C, and ApoB.

You will also gain clarity on when to incorporate additional risk markers such as Lp(a) and coronary artery calcium, how to approach triglyceride management in the context of both ASCVD and pancreatitis risk, and how to apply evidence-based strategies across diverse patient populations, including those with diabetes, chronic kidney disease, and other high-risk conditions.

Lecturer

Roger S. Blumenthal, MD, FASPC, is The Kenneth Jay Pollin Professor of Cardiology, Professor of Medicine, and the Director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, MD.  Dr. Blumenthal graduated with honors from both the Landon School in Bethesda and Johns Hopkins University.   He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. 

He did his Internal Medicine and Cardiology fellowship training at The Johns Hopkins University School of Medicine before joining the Hopkins Cardiology faculty. Dr. Blumenthal was the 2018 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was the 2019 recipient of the Society of Cardiovascular Computed Tomography (SCCT) Arthur S. Agatston Cardiovascular Disease Prevention Award for his work in selective use of cardiac CT to improve cardiovascular risk assessment.

His principal clinical and research interests involve 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk for their age and those at very low risk of cardiovascular disease & 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment, and prevention of cardiovascular disease.

Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.  He has co-authored more than 1,000 scientific publications on many aspects of cardiovascular disease management. 

Moderator

Ashish Sarraju, MD is Associate Staff in Preventive Cardiology at the Miller Heart, Vascular, and Thoracic Institute at the Cleveland Clinic Cleveland Ohio, and a researcher with the Cleveland Clinic Coordinating Center for Clinical Research (C5research). Dr. Sarraju trained at Stanford University as a resident and Chief Resident in internal medicine, where he stayed for fellowship and as Chief Fellow in Cardiovascular Medicine. He completed a postdoctoral research training funded by the American Heart Association focused on health tech and innovation. He received the Edwin Alderman award for Excellence in Clinical Research at Stanford.

At the Cleveland Clinic, he focuses on dyslipidemias and familial hypercholesterolemia. His research focuses on clinical trials, epidemiologic studies, and AI and tech to address gaps in preventive cardiology. His original research has been published in leading journals. He serves in leadership positions for phase 1 through 3 randomized trials. He is a member of C5research, the academic research organization of the Cleveland Clinic. He serves as a peer reviewer for major journals, on several AHA grant review committees, and is a member of the AHA Epidemiology and Prevention Statistics committee.

He received a Top Educator award at the Cleveland Clinic in 2023.